Jager MJ - Search Results

1

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.

de Lange MJ, Razzaq L, Versluis M, Verlinde S, Dogrusöz M, Böhringer S, Marinkovic M, Luyten GP, de Keizer RJ, de Gruijl FR, Jager MJ, van der Velden PA. de Lange MJ, et al. Among authors: jager mj. PLoS One. 2015 Sep 14;10(9):e0138002. doi: 10.1371/journal.pone.0138002. eCollection 2015. PLoS One. 2015. PMID: 26368812 Free PMC article.

2

Heat shock protein expression in the eye and in uveal melanoma.

Missotten GS, Journée-de Korver JG, de Wolff-Rouendaal D, Keunen JE, Schlingemann RO, Jager MJ. Missotten GS, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3059-65. doi: 10.1167/iovs.02-1038. Invest Ophthalmol Vis Sci. 2003. PMID: 12824252

3

Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.

van der Velden PA, Zuidervaart W, Hurks MHMH, Pavey S, Ksander BR, Krijgsman E, Frants RR, Tensen CP, Willemze R, Jager MJ, Gruis NA. van der Velden PA, et al. Among authors: jager mj. Int J Cancer. 2003 Sep 10;106(4):472-479. doi: 10.1002/ijc.11262. Int J Cancer. 2003. PMID: 12845640 Free article.

4

Maintenance of immune tolerance depends on normal tissue homeostasis.

Boonman ZF, van Mierlo GJ, Fransen MF, de Keizer RJ, Jager MJ, Melief CJ, Toes RE. Boonman ZF, et al. Among authors: jager mj. J Immunol. 2005 Oct 1;175(7):4247-54. doi: 10.4049/jimmunol.175.7.4247. J Immunol. 2005. PMID: 16177064

5

Epigenetic inactivation of RASSF1a in uveal melanoma.

Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA. Maat W, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2007 Feb;48(2):486-90. doi: 10.1167/iovs.06-0781. Invest Ophthalmol Vis Sci. 2007. PMID: 17251440

6

Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.

Maat W, Kilic E, Luyten GP, de Klein A, Jager MJ, Gruis NA, Van der Velden PA. Maat W, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2008 Jan;49(1):23-7. doi: 10.1167/iovs.07-0722. Invest Ophthalmol Vis Sci. 2008. PMID: 18172070

7

Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.

Maat W, Beiboer SH, Jager MJ, Luyten GP, Gruis NA, van der Velden PA. Maat W, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1291-8. doi: 10.1167/iovs.07-1135. Invest Ophthalmol Vis Sci. 2008. PMID: 18385040

8

Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.

El Filali M, Homminga I, Maat W, van der Velden PA, Jager MJ. El Filali M, et al. Among authors: jager mj. Mol Vis. 2008 Sep 24;14:1752-9. Mol Vis. 2008. PMID: 18836566 Free PMC article.

9

Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.

Maat W, van der Slik AR, Verhoeven DH, Alizadeh BZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T, Koning F, Jager MJ, van Bergen J. Maat W, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2888-95. doi: 10.1167/iovs.08-2733. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234348

10

Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.

Ly LV, Odish OF, Wolff-Rouendaal Dd, Missotten GS, Luyten GP, Jager MJ. Ly LV, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):658-65. doi: 10.1167/iovs.09-3824. Epub 2009 Sep 24. Invest Ophthalmol Vis Sci. 2010. PMID: 19797220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page